Search

Search Constraints

You searched for: Author/Creator Fu, Cheng

Search Results

1. 78 T-Cell, MHC i, and tumor intrinsic gene signatures predict clinical benefit and resistance to tislelizumab monotherapy in pretreated PD-L1+ urothelial carcinoma. (10th December 2020)

2. 78 T-Cell, MHC i, and tumor intrinsic gene signatures predict clinical benefit and resistance to tislelizumab monotherapy in pretreated PD-L1+ urothelial carcinoma. (9th November 2020)

4. Advanced Vehicle Miles Traveled Estimation Methods for Non-Federal Aid System Roadways Using GPS Vehicle Trajectory Data and Statistical Power Analysis. Issue 11 (November 2019)

5. Anlotinib Versus Sunitinib as First‐Line Treatment for Metastatic Renal Cell Carcinoma: A Randomized Phase II Clinical Trial. (22nd March 2019)